Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice - Takeaways - MDSpire

Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice

  • By

  • Bin Li

  • Yifei Dong

  • Yifei Dai

  • Mengpei Zhang

  • Zhenwei Zou

  • Hai Yang

  • June 29, 2026

  • 0 min

Share

  • 1

    Fusobacterium nucleatum is linked to colorectal cancer through mechanisms like oncogenic signaling activation and immune microenvironment modulation.

  • 2

    Technological advancements have improved Fn detection, transitioning from culture-based methods to high-resolution techniques like quantitative PCR and NGS.

  • 3

    Fn subspecies differentiation is crucial for understanding its role in CRC, with F. animalis associated with adverse clinical outcomes.

  • 4

    Current challenges in clinical translation of Fn diagnostics include subspecies heterogeneity and non-standardized diagnostic platforms.

  • 5

    Future research should focus on establishing a causal relationship between Fn and CRC, optimizing noninvasive detection, and developing targeted therapies.

Original Source(s)

Taxonomy, carcinogenic mechanisms, and advanced molecular diagnosis of Fusobacterium nucleatum in colorectal cancer: from bench to clinical practice

  • by Bin Li, Yifei Dong, Yifei Dai, Mengpei Zhang, Zhenwei Zou, Hai Yang

  • June 29, 2026

Related Content

Editorial: Advances in proctology and colorectal surgery, volume II

Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status

Diagnostic performance of 18F-FDG PET-CT and SPECT for bone metastases from colorectal cancer: a retrospective study